Vetigenics Inc. Email Format
Biotechnology ResearchPennsylvania, United States11-50 Employees
Vetigenics Inc. is a biotechnology research company focused on leveraging a dog’s own immune system to develop antibody-based therapies for veterinary health, particularly targeting cancer and other diseases in companion animals. Based in Philadelphia, Pennsylvania, the firm emphasizes canine-specific immunotherapies derived from a comprehensive library of canine single chain fragment variable (scFv) antibodies, enabling rapid isolation and engineering into various therapeutic formats while aiming to reduce immunogenicity compared with other approaches. Its work targets veterinarians and pet owners seeking advanced treatment options that can extend and improve the lives of dogs and cats. Founded by researchers affiliated with the University of Pennsylvania, Vetigenics collaborates with a network of experts in animal and human health to advance a portfolio of CANIBODY immunomodulators through development and testing. A recent public development notes ongoing efforts to pursue antibody treatments for cancers and other diseases in companion animals, reflecting the company’s ongoing progress in its field.
1-888-653-2347 
support@leadiq.com 
